Literature DB >> 19759477

Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.

Elfatah Elnifro1, A K Nisha, Musbah Almabsoot, Ali Daeki, Nuri Mujber, Jose Muscat.   

Abstract

BACKGROUND: Human parvovirus B19 has been implicated as a primary etiologic agent of erythema infectiosum (fifth disease) and aplastic crisis in patients with chronic haemolytic anemias. Human parvovirus B19 is known to be associated with adverse effects on fetuses such as hydrops fetalis, intrauterine fetal death, and chronic anaemia in immunocompromized individuals. The objective of this study was to assess the seroprevalence of human parvovirus B19 among the pregnant women in Tripoli, Libya.
METHODOLOGY: A total number of 150 participants were included in the study, consisting of women of child-bearing age ranging from 18 to 41 years, and divided into age groups as follows: < or = 21 years, 22-27, 28-32, 33-37, and > or = 38 years. Specific IgM and IgG antibodies were measured using a commercial ELISA kit.
RESULTS: IgG was observed to be prevalent (61%) among the women of child-bearing age. The sero-prevalence of IgM was found to be 5% overall and there was no detectable IgM in the age group between 33 and 37.
CONCLUSION: The presence of IgG and absence of IgM indicate immunity to primary infection, but a significant percentage of child-bearing aged women are at risk of primary infection with parvovirus B19 which could adversely affect their pregnancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759477     DOI: 10.3855/jidc.38

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.

Authors:  O Adam; T Makkawi; U Reber; H Kirberg; A M Eis-Hübinger
Journal:  Epidemiol Infect       Date:  2014-03-20       Impact factor: 4.434

3.  Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia.

Authors:  Bamidele Abiodun Iwalokun; Senapon Olusola Iwalokun; Semande Olufunmilayo Hodonu
Journal:  J Biomed Res       Date:  2013-06-15

4.  The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2013.

Authors:  Shahram Habibzadeh; Hadi Peeri-Doghaheh; Jafar Mohammad-Shahi; Elham Mobini; Samira Shahbazzadegan
Journal:  Iran J Microbiol       Date:  2016-06

5.  The magnitude and correlates of Parvovirus B19 infection among pregnant women attending antenatal clinics in Mwanza, Tanzania.

Authors:  Mariam M Mirambo; Fatma Maliki; Mtebe Majigo; Martha F Mushi; Nyambura Moremi; Jeremiah Seni; Dismas Matovelo; Stephen E Mshana
Journal:  BMC Pregnancy Childbirth       Date:  2017-06-07       Impact factor: 3.007

6.  Molecular-genetic characterization of human parvovirus B19 prevalent in Kerala State, India.

Authors:  Dayakar Seetha; Heera R Pillai; Sai Ravi Chandra Nori; Sanu Ghosh Kalpathodi; Vineetha P Thulasi; Radhakrishnan R Nair
Journal:  Virol J       Date:  2021-05-05       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.